Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

11,595 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Reproduction of the Antitumor Effect of Cisplatin and Cetuximab Using a Three-dimensional Spheroid Model in Oral Cancer.
Ono K, Sato K, Nakamura T, Yoshida Y, Murata S, Yoshida K, Kanemoto H, Umemori K, Kawai H, Obata K, Ryumon S, Hasegawa K, Kunisada Y, Okui T, Ibaragi S, Nagatsuka H, Sasaki A. Ono K, et al. Among authors: yoshida k, yoshida y. Int J Med Sci. 2022 Jul 18;19(8):1320-1333. doi: 10.7150/ijms.74109. eCollection 2022. Int J Med Sci. 2022. PMID: 35928727 Free PMC article.
EpEX, the soluble extracellular domain of EpCAM, resists cetuximab treatment of EGFR-high head and neck squamous cell carcinoma.
Umemori K, Ono K, Eguchi T, Kawai H, Nakamura T, Ogawa T, Yoshida K, Kanemoto H, Sato K, Obata K, Ryumon S, Yutori H, Katase N, Okui T, Nagatsuka H, Ibaragi S. Umemori K, et al. Among authors: yoshida k. Oral Oncol. 2023 Jul;142:106433. doi: 10.1016/j.oraloncology.2023.106433. Epub 2023 May 24. Oral Oncol. 2023. PMID: 37236125 Free article.
11,595 results
You have reached the last available page of results. Please see the User Guide for more information.